enfuvirtide, T-20 (Fuzeon)

Type of Drug: Fusion Inhibitor

Fusion inhibitors work by stopping the HIV virus from getting into your body's healthy cells in the first place.

Approved adult dosing

90 mg (in 1 mL solution) injection

one injection under the skin, two times a day

• Morning

Fuzeon

• Evening

Fuzeon

Notes on taking this medication

• One vial contains a white powder, which is the medication (Fuzeon); another vial contains sterile water; withdraw the water with a syringe and mix into the vial with the Fuzeon
• You can prepare both doses at the same time, but should store the second vial in a refrigerator for use later on the same day
• Keep uncapped vial tops, syringes, and your hands clean while preparing Fuzeon
• Draw Fuzeon solution into the syringe only when you are ready to inject
• Rotate injection sites for each injection
• Never inject Fuzeon into a vein or muscle

Side effects

• At injection site: redness; pain or tenderness; swelling; bumps; hardening of skin
• Very rare serious allergic reactions: symptoms include trouble breathing; fever with vomiting and rash; swollen feet

SOURCE: United States Department of Veterans Affairs. "Drug Dosing Toolkit, Fuzeon (enfuvirtide, T-20)."
<http://www.hiv.va.gov/vahiv?page=treat-drug-Fuzeon>

Report Problems to the Food and Drug Administration You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088. Need help identifying pills and medications? Use the pill identifier tool on RxList.